Literature DB >> 23175789

Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody.

Aaron G Schmidt1, Huafeng Xu, Amir R Khan, Timothy O'Donnell, Surender Khurana, Lisa R King, Jody Manischewitz, Hana Golding, Pirada Suphaphiphat, Andrea Carfi, Ethan C Settembre, Philip R Dormitzer, Thomas B Kepler, Ruijun Zhang, M Anthony Moody, Barton F Haynes, Hua-Xin Liao, David E Shaw, Stephen C Harrison.   

Abstract

Affinity maturation refines a naive B-cell response by selecting mutations in antibody variable domains that enhance antigen binding. We describe a B-cell lineage expressing broadly neutralizing influenza virus antibodies derived from a subject immunized with the 2007 trivalent vaccine. The lineage comprises three mature antibodies, the unmutated common ancestor, and a common intermediate. Their heavy-chain complementarity determining region inserts into the conserved receptor-binding pocket of influenza HA. We show by analysis of structures, binding kinetics and long time-scale molecular dynamics simulations that antibody evolution in this lineage has rigidified the initially flexible heavy-chain complementarity determining region by two nearly independent pathways and that this preconfiguration accounts for most of the affinity gain. The results advance our understanding of strategies for developing more broadly effective influenza vaccines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23175789      PMCID: PMC3538208          DOI: 10.1073/pnas.1218256109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

Review 2.  Germinal centers.

Authors:  Gabriel D Victora; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

3.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

4.  Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Bryan S Briney; Scott A Smith; Christopher F Basler; James E Crowe
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

5.  Structural insights into the evolution of an antibody combining site.

Authors:  G J Wedemayer; P A Patten; L H Wang; P G Schultz; R C Stevens
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

6.  OpenStructure: a flexible software framework for computational structural biology.

Authors:  Marco Biasini; Valerio Mariani; Jürgen Haas; Stefan Scheuber; Andreas D Schenk; Torsten Schwede; Ansgar Philippsen
Journal:  Bioinformatics       Date:  2010-08-23       Impact factor: 6.937

7.  Improved side-chain torsion potentials for the Amber ff99SB protein force field.

Authors:  Kresten Lindorff-Larsen; Stefano Piana; Kim Palmo; Paul Maragakis; John L Klepeis; Ron O Dror; David E Shaw
Journal:  Proteins       Date:  2010-06

8.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

9.  Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard.

Authors:  Thomas C Terwilliger; Ralf W Grosse-Kunstleve; Pavel V Afonine; Nigel W Moriarty; Peter H Zwart; Li Wei Hung; Randy J Read; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-12-05

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  130 in total

1.  Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses.

Authors:  Natalie J Thornburg; David P Nannemann; David L Blum; Jessica A Belser; Terrence M Tumpey; Shyam Deshpande; Gloria A Fritz; Gopal Sapparapu; Jens C Krause; Jeong Hyun Lee; Andrew B Ward; David E Lee; Sheng Li; Katie L Winarski; Benjamin W Spiller; Jens Meiler; James E Crowe
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Structural basis for Marburg virus neutralization by a cross-reactive human antibody.

Authors:  Takao Hashiguchi; Marnie L Fusco; Zachary A Bornholdt; Jeffrey E Lee; Andrew I Flyak; Rei Matsuoka; Daisuke Kohda; Yusuke Yanagi; Michal Hammel; James E Crowe; Erica Ollmann Saphire
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

3.  Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.

Authors:  Minsun Hong; Peter S Lee; Ryan M B Hoffman; Xueyong Zhu; Jens C Krause; Nick S Laursen; Sung-Il Yoon; Langzhou Song; Lynda Tussey; James E Crowe; Andrew B Ward; Ian A Wilson
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

4.  Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.

Authors:  Cong Chen; Liguo Liu; Yan Xiao; Sheng Cui; Jianmin Wang; Qi Jin
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 5.  From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Authors:  Carole Henry; Anna-Karin E Palm; Florian Krammer; Patrick C Wilson
Journal:  Trends Immunol       Date:  2017-08-31       Impact factor: 16.687

Review 6.  Structural insights into the design of novel anti-influenza therapies.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  Nat Struct Mol Biol       Date:  2018-02-02       Impact factor: 15.369

7.  Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity.

Authors:  Nadia Anikeeva; Maria Steblyanko; Svetlana Fayngerts; Natalya Kopylova; Deborah J Marshall; Gordon D Powers; Takami Sato; Kerry S Campbell; Yuri Sykulev
Journal:  Eur J Immunol       Date:  2014-06-05       Impact factor: 5.532

Review 8.  Progress toward improved understanding of antibody maturation.

Authors:  Sandor Vajda; Kathryn A Porter; Dima Kozakov
Journal:  Curr Opin Struct Biol       Date:  2021-02-17       Impact factor: 6.809

9.  Increased Fab thermoresistance via VH-targeted directed evolution.

Authors:  Kevin C Entzminger; Jennifer L Johnson; Jeongmin Hyun; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2015-08-16       Impact factor: 1.650

10.  Overlapping hotspots in CDRs are critical sites for V region diversification.

Authors:  Lirong Wei; Richard Chahwan; Shanzhi Wang; Xiaohua Wang; Phuong T Pham; Myron F Goodman; Aviv Bergman; Matthew D Scharff; Thomas MacCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.